LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer.
about
SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway.Lrig1 is a positive prognostic marker in hepatocellular carcinoma.Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro.MicroRNA-590-3p enhances the radioresistance in glioblastoma cells by targeting LRIG1.
P2860
LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
LRIG1, a 3p tumor suppressor, ...... ced gene in colorectal cancer.
@en
type
label
LRIG1, a 3p tumor suppressor, ...... ced gene in colorectal cancer.
@en
prefLabel
LRIG1, a 3p tumor suppressor, ...... ced gene in colorectal cancer.
@en
P2093
P1476
LRIG1, a 3p tumor suppressor, ...... ced gene in colorectal cancer.
@en
P2093
Changhua Kou
Haixin Qian
Huijie Zhuang
P304
P356
10.1016/J.BBRC.2015.06.173
P407
P577
2015-07-06T00:00:00Z